Author:
Alalikhan Abbas,Ebrahimi Safieh,Aliee Ali,Mirzavi Farshad,Hashemy Seyed Isaac
Publisher
Springer Science and Business Media LLC
Reference38 articles.
1. Xi Y, Xu P. Global colorectal cancer burden in 2020 and projections to 2040. Transl Oncol. 2021;14:101174. https://doi.org/10.1016/j.tranon.2021.101174
2. Hossain MS, Karuniawati H, Jairoun AA, Urbi Z, Ooi J, John A, Lim YC, Kibria KMK, Mohiuddin AKM, Ming LC, Goh KW. Hadi,Colorectal Cancer: a review of Carcinogenesis, Global Epidemiology, Current challenges, risk factors, preventive and treatment strategies. Cancers (Basel). 2022;14. https://doi.org/10.3390/cancers14071732
3. Rawla P, Sunkara T. Barsouk,Epidemiology of colorectal cancer: incidence, mortality, survival, and risk factors. Gastroenterol Review/Przegląd Gastroenterologiczny. 2019;14:89–103.
4. Vodenkova S, Buchler T, Cervena K, Veskrnova V, Vodicka P. Vymetalkova,5-fluorouracil and other fluoropyrimidines in colorectal cancer: past, present and future. Pharmacol Ther. 2020;206:107447.
5. Sethy C. Kundu,5-Fluorouracil (5-FU) resistance and the new strategy to enhance the sensitivity against cancer: implication of DNA repair inhibition. Biomed Pharmacother. 2021;137:111285.